SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-15-000062
Filing Date
2015-05-11
Accepted
2015-05-11 08:38:24
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-3311510q.htm 10-Q 963950
2 EXHIBIT 31.1 lgnd_33115exhibit311.htm EX-31.1 24684
3 EXHIBIT 31.2 lgnd_33115exhibit312.htm EX-31.2 24665
4 EXHIBIT 32.1 lgnd_33115exhibit321.htm EX-32.1 15402
  Complete submission text file 0000886163-15-000062.txt   9899749

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT lgnd-20150331.xml EX-101.INS 1549226
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20150331.xsd EX-101.SCH 58156
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20150331_cal.xml EX-101.CAL 86145
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20150331_def.xml EX-101.DEF 278984
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20150331_lab.xml EX-101.LAB 870855
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20150331_pre.xml EX-101.PRE 462645
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 15849011
SIC: 2834 Pharmaceutical Preparations